-
14-07-2021, 09:50 AM
#431
Originally Posted by RRR
Most patients don't actually mind paying $5 per drug (a prescription may have several drugs)! I was surprised by this - as mentioned most of my prescriptions goes to regular pharmacies such as unichem. Not sure whether the Govt will scrap this fee...
Only a minority of patients request their prescriptions to be sent chemist warehouse etc. Many regular pharmacies have started to waive the prescription fee..
Well I would think if GXH wanted to stay "in the game" they too will waive the prescription fee.
Therefore GXH investors will need to consider what affect this will have on GXH's earnings.I would guess huge.
-
14-07-2021, 09:58 AM
#432
Member
Originally Posted by percy
Well I would think if GXH wanted to stay "in the game" they too will waive the prescription fee.
Therefore GXH investors will need to consider what affect this will have on GXH's earnings.I would guess huge.
Some of their pharmacies are waiving the fee, I guess those ones closer to the likes of chemist warehouse. Pharmacy business is competitive for sure but they are not going out of business soon. It is obvious for us who write prescriptions on a daily basis!!
GXH other businesses are growing very well - medical practice (The Doctors brand) and community health. GXH is not all about pharmacies
-
14-07-2021, 11:23 AM
#433
Originally Posted by RRR
Some of their pharmacies are waiving the fee, I guess those ones closer to the likes of chemist warehouse. Pharmacy business is competitive for sure but they are not going out of business soon. It is obvious for us who write prescriptions on a daily basis!!
GXH other businesses are growing very well - medical practice (The Doctors brand) and community health. GXH is not all about pharmacies
Pharmacies still account for over half of GXH's revenue,and both their revenue and margins will continue to come under pressure,as will their overheads,including rents,staffing and insurances.
-
14-07-2021, 08:29 PM
#434
Member
Bad sign again! I am trying to use VCP analysis for GXH. However, it never successfully reaches to $1.30- $1.40 price range again after Jan 2020. That means if it has ability to reach $1.40 -$1.50 later on, it have very high possibility failed to break out and climb upwards. Unless.....
Fundamentally, it looks great, but technically, it sucks........
Screenshot 2021-07-14 202716.jpg
Last edited by flyinglizard; 14-07-2021 at 08:36 PM.
-
28-07-2021, 02:03 PM
#435
Yippee - share price breaks through 120
Should carry on with it now .....130 then 140 then 150 ...
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
28-07-2021, 02:07 PM
#436
I see many covid vaccination centres are branded Unichem - assung they doing the jabs
Hope they making zillions for doing this community service
Last edited by winner69; 28-07-2021 at 02:17 PM.
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
28-07-2021, 02:15 PM
#437
Member
Originally Posted by winner69
I see many covid vaccination centres are branded Unichem
Hope they making zillions for doing this community service
Some NZ post offices closed and moved into Pharmacy store in CHCH.
-
31-07-2021, 10:23 AM
#438
GXH board bemoan lack of analyst coverage.
Who can blame analysts when GXH are woeful at ‘communicating’ to the market
Businessweek had this snippet
The company’s approach to communications was summed up when a shareholder asked how the company had traded over the first three months of the new financial year. The response was that Green Cross, unlike other companies, doesn’t disclose these specific figures to investors
Anyway share price holding above 120 ….probably be 150 if the Board were a bit more enthusiastic in telling their story
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
31-07-2021, 02:44 PM
#439
Originally Posted by winner69
GXH board bemoan lack of analyst coverage.
Who can blame analysts when GXH are woeful at ‘communicating’ to the market
Businessweek had this snippet
The company’s approach to communications was summed up when a shareholder asked how the company had traded over the first three months of the new financial year. The response was that Green Cross, unlike other companies, doesn’t disclose these specific figures to investors
Anyway share price holding above 120 ….probably be 150 if the Board were a bit more enthusiastic in telling their story
Agreed. No guidance reported. A website that looks out of date. No investor days, no marketing material.
-
31-07-2021, 03:42 PM
#440
Originally Posted by value_investor
Agreed. No guidance reported. A website that looks out of date. No investor days, no marketing material.
Just confirms they don't give a stuff about 'retail' shareholders - probably seen as a bloody nuisance
A bit of do as we say from Bagnall/Merton doesn't help and Ellis if far from charismatic.
Maybe the company will be a lot more will be forthcoming when those two dudes want out and they need capital markets to front up with zillions
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks